Clinical Trials Browser

OTHER × Pancreatic Neoplasms × Lapatinib × Clear all

NCT00881621 2025-03-03

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Phase 2 Terminated

17 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00447122 2022-03-08

BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer

Phase 1 Terminated

25 enrolled 9 charts

Gastrointestinal

Pancreatic Neoplasms